# Sublingual Versus Intranasal Administration of Dexmedetomidine for Sedation of Children Undergoing Dental Treatment

> **NCT04237532** · PHASE2,PHASE3 · COMPLETED · sponsor: **Nourhan M.Aly** · enrollment: 42 (actual)

## Conditions studied

- Anti-anxiety Agents
- Moderate Sedation

## Interventions

- **DRUG:** Intranasal Dexmedetomidine
- **DRUG:** Sublingual Dexmedetomidine

## Key facts

- **NCT ID:** NCT04237532
- **Lead sponsor:** Nourhan M.Aly
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-27
- **Primary completion:** 2020-08-01
- **Final completion:** 2020-08-10
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2020-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04237532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04237532, "Sublingual Versus Intranasal Administration of Dexmedetomidine for Sedation of Children Undergoing Dental Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04237532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*